Exicure adds new sites to Phase Ib/II trial of AST-008
Exicure has added four new clinical trial sites for its Phase Ib/II trial of AST-008 for the treatment of various…
Exicure has added four new clinical trial sites for its Phase Ib/II trial of AST-008 for the treatment of various…
Bio-Thera Solutions has begun a Phase III clinical trial to investigate the efficacy and safety of BAT8001 for the treatment…